438 related articles for article (PubMed ID: 21681905)
1. Prognostic role of preprocedural glucose levels on short- and long-term outcome in patients undergoing percutaneous coronary revascularization.
Nusca A; Patti G; Marino F; Mangiacapra F; D'Ambrosio A; Di Sciascio G
Catheter Cardiovasc Interv; 2012 Sep; 80(3):377-84. PubMed ID: 21681905
[TBL] [Abstract][Full Text] [Related]
2. High sensitivity C-reactive protein and outcomes following percutaneous coronary intervention in contemporary practice.
Herrmann J; Lennon RJ; Barsness GW; Sandhu GS; Gulati R; Best PJ; Sorajja P; Bresnahan JF; Mathew V; Bell MR; Prasad A
Circ Cardiovasc Interv; 2012 Dec; 5(6):783-90. PubMed ID: 23212397
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of neointimal hyperplasia without neoatherosclerosis after drug-eluting stent implantation.
Kim JS; Lee JH; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
JACC Cardiovasc Imaging; 2014 Aug; 7(8):788-95. PubMed ID: 25051946
[TBL] [Abstract][Full Text] [Related]
4. Impact of stress hyperglycemia on in-hospital stent thrombosis and prognosis in nondiabetic patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
Zhang JW; Zhou YJ; Cao SJ; Yang Q; Yang SW; Nie B
Coron Artery Dis; 2013 Aug; 24(5):352-6. PubMed ID: 23835666
[TBL] [Abstract][Full Text] [Related]
5. Reduced antiplatelet therapy after drug-eluting stenting: multicenter Janus Flex carbostent implantation with short dual antiplatelet treatment for 2 or 6 months-MATRIX study.
Cassese S; De Luca G; Villari B; Berti S; Bellone P; Alfieri A; Montinaro A; Quaranta G; Marraccini P; Piscione F;
Catheter Cardiovasc Interv; 2012 Sep; 80(3):408-16. PubMed ID: 21735531
[TBL] [Abstract][Full Text] [Related]
6. Elective percutaneous coronary intervention: the relationship between preprocedural blood glucose levels and periprocedural myocardial injury.
Madani M; Alizadeh K; Ghazaee SP; Zavarehee A; Abdi S; Shakerian F; Salehi N; Firouzi A
Tex Heart Inst J; 2013; 40(4):410-7. PubMed ID: 24082370
[TBL] [Abstract][Full Text] [Related]
7. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
Puymirat E; Mangiacapra F; Peace A; Ntarladimas Y; Conte M; Bartunek J; Vanderheyden M; Wijns W; de Bruyne B; Barbato E
Arch Cardiovasc Dis; 2013 Nov; 106(11):554-61. PubMed ID: 24231052
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy and safety of biodegradable polymer-based sirolimus-eluting stents in patients with diabetes mellitus insight from the 4-year results of the create study.
Li Y; Han Y; Zhang L; Jing Q; Wang X; Yan G; Ma Y; Wang G; Wang S; Chen X; Yang L; Zhu G; Liu H; Jiang T
Catheter Cardiovasc Interv; 2013 Jun; 81(7):1127-33. PubMed ID: 22945767
[TBL] [Abstract][Full Text] [Related]
9. Effects of abciximab and preprocedural glycemic control in diabetic patients undergoing elective coronary stenting.
De Luca L; De Persio G; Minati M; Iacoboni C; Fedele F
Am Heart J; 2005 Jun; 149(6):1135. PubMed ID: 15976799
[TBL] [Abstract][Full Text] [Related]
10. Stent fracture is associated with a higher mortality in patients with type-2 diabetes treated by implantation of a second-generation drug-eluting stent.
Ge Z; Liu ZZ; Kan J; Zhang JJ; Li SJ; Tian NL; Ye F; Qian XS; Yang S; Chen MX; Rab TS; Chen SL
Int J Cardiovasc Imaging; 2017 Dec; 33(12):1873-1881. PubMed ID: 28631105
[TBL] [Abstract][Full Text] [Related]
11. Differential long-term outcomes of zotarolimus-eluting stents compared with sirolimus-eluting and paclitaxel-eluting stents in diabetic and nondiabetic patients: two-year subgroup analysis of the ZEST randomized trial.
Jang SJ; Park DW; Kim WJ; Kim YH; Yun SC; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
Catheter Cardiovasc Interv; 2013 Jun; 81(7):1106-14. PubMed ID: 22899589
[TBL] [Abstract][Full Text] [Related]
12. One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: results from the Diabetic Argentina Registry (DEAR).
Mieres J; Fernandez-Pereira C; Risau G; Solorzano L; Pauletto R; Rodriguez-Granillo AM; Rubilar B; Stella P; Rodriguez AE
Cardiovasc Revasc Med; 2012; 13(5):265-71. PubMed ID: 22796496
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation.
Musumeci G; Rossini R; Lettieri C; Capodanno D; Romano M; Rosiello R; Guagliumi G; Valsecchi O; Gavazzi A; Angiolillo DJ
Catheter Cardiovasc Interv; 2012 Sep; 80(3):395-405. PubMed ID: 22109961
[TBL] [Abstract][Full Text] [Related]
14. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
[TBL] [Abstract][Full Text] [Related]
15. Impact of angiographic and intravascular ultrasound features on clinical outcome after sirolimus-eluting stent implantation for de-novo lesions in nondiabetic and type 2 diabetic patients.
Du R; Zhang RY; Zhu ZB; Zhang Q; Hu J; Yang ZK; Yan ZJ; Lv AK; Ding FH; Zhang JS; Shen WF
Coron Artery Dis; 2010 May; 21(3):175-81. PubMed ID: 20305549
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of everolimus-eluting stents versus paclitaxel-eluting stents in a diabetic population.
Laynez A; Sardi G; Hauville C; Barbash IM; Pakala R; Torguson R; Xue Z; Satler LF; Pichard AD; Waksman R
Catheter Cardiovasc Interv; 2013 Apr; 81(5):759-65. PubMed ID: 22488756
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention.
Napan S; Kashinath RC; Kadri S; Orig MN; Khadra S
Coron Artery Dis; 2010 Aug; 21(5):261-5. PubMed ID: 20555264
[TBL] [Abstract][Full Text] [Related]
18. Outcomes after percutaneous coronary intervention with stents in patients treated with thoracic external beam radiation for cancer.
Liang JJ; Sio TT; Slusser JP; Lennon RJ; Miller RC; Sandhu G; Prasad A
JACC Cardiovasc Interv; 2014 Dec; 7(12):1412-20. PubMed ID: 25459527
[TBL] [Abstract][Full Text] [Related]
19. Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up.
Davies WR; Brown AJ; Watson W; McCormick LM; West NE; Dutka DP; Hoole SP
Circ Cardiovasc Interv; 2013 Jun; 6(3):246-51. PubMed ID: 23696599
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of provisional side-branch T-stenting for the treatment of unprotected distal left main coronary artery disease.
De Luca L; Altamura L; Corvo P; De Persio G; Ghini AS; Petrolini A; Aurigemma C; Tomai F
Catheter Cardiovasc Interv; 2011 May; 77(6):765-72. PubMed ID: 21413124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
